Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.

Source:http://linkedlifedata.com/resource/pubmed/id/11027431

Download in:

View as

General Info

PMID
11027431